13th Congress of the European Hematology Association

Search’n Build™


M. Schrappe  

Characteristics and management of patients with very high risk childhood acute lymphoblastic leukemia
2008-06-13 - English


 F. Rickles  

Hemostasis and cancer
2008-06-13 - English

1. Pathophysiology of thrombosis in cancer;
2. Role of tissue factor(TF)in tumor cell signaling and angiogenesis through protease-activated receptors (PARs);
3. Molecular regulation of TF, other blood coagulation factors, platelet function and fibrinolysis by tumor...(more)


W. van Heerde  

Past and present screening assays to evaluate hemostasis
2008-06-13 - English

The aim of this presentation is to give an overview about pro and cons of the currrent screening assays to detect abnormalities in hemostasis. Secondly, new initiatives to screen for hemostatic abberations will be discussed.


Jorgen Ingerslev  

Treatment of bleeding disorders with pro-hemostatic drugs
2008-06-13 - English


 S. Ehl  

Autoimmune neutropenia
2008-06-13 - English


P. Ghia  

Clues on the origin and behaviour of chronic lymphocytic leukemia cells
2008-06-13 - English


D. Webb  

Management of adolescents with acute lymphoblastic leukemia: implications for adult therapy
2008-06-13 - English


S. Gore  

Defining the role of epigenetic therapy in myelodysplastic syndromes
2008-06-13 - English


H. Heslop  

Cellular therapy to rebuild immunity after stem cell transplantation
2008-06-13 - English


H. Lokhorst  

Allogeneic transplants and immune intervention in multiple myeloma
2008-06-13 - English


 L. Luzzatto  

New insights into paroxysmal nocturnal haemoglobinuria
2008-06-13 - English


 G. Barosi  

Management of primary myelofibrosis
2008-06-13 - English


 R. Mesa  

Blastic transformation in myeloproliferative disorders: science and therapy
2008-06-13 - English

The BCR-ABL negative chronic myeloproliferative disorders (MPDs) of essential thrombocythemia, polycythemia vera and primary myelofibrosis have an increasing predisposition to transforming to overt acute leukemia or MPD-Blast Phase (MPD-BP). The development of MPD-BP is...(more)


Marco Cattaneo  

Congenital platelet disorders
2008-06-13 - English


 Paul Imbach  

Immunopathogenesis, immunomodulation and management of immune thrombocytopenic purpura in children
2008-06-13 - English

Definition, diagnosis of childhood ITP, pathognesis of ITP, therapeutic immunomodulation of ITP, platelet stimulation by thrombopoietin receptor analoga, clinical presentation and practical management of ITP, todays clinical research by the intercontinental cooperative ITP study group.


Thierry Facon  

Frontline treatment in multiple myeloma patients ineligible for stem cell transplantation
2008-06-13 - English


 D. Re  

Biology of Hodgkin lymphoma
2008-06-13 - English


 S. Proctor  

Hodgkin lymphoma in the elderly: current status and future directions
2008-06-13 - English

An overview of the current status of management of Hodgkin lymphoma in patients over 60 years.


A. Younes  

Targeted therapy of diffuse large cell lymphoma
2008-06-13 - English


Willem E. Fibbe  

Welcome to the 13th congress of EHA
2008-06-13 - English


C. Mecucci  

Presentation EHA-José Carreras Young Investigator Fellowship & EHA Fellowships
2008-06-13 - English


Mike Greaves  

Relationship between academia and pharma
2008-06-14 - English




Marieke Essers  

IFN-A Promotes Proliferation of Dormant HSCs in vivo, Making Them Susceptible to Elimination by Chemotherapy
2008-06-14 - English


 R. Dalla Favera  

Molecular pathogenesis of B cell lymphomas
2008-06-14 - English


M. Hallek  

Chronic lymphoid leukemia - current concepts of molecular pathogenesis and therapy
2008-06-15 - English

Novel aspects in the biology of CLL.
Use of prognostic factors and in particular genetic markers in CLL.
Novel therapeutic approaches in CLL.